We are live on
!
Find out more
CRC
Curi RMB Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
18.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.52%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+312.51%
AUM
$2.81B
AUM Growth
+$127M
(+4.7%)
Cap. Flow
-$91.8M
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
17.47%
Holding
504
New
39
Increased
117
Reduced
218
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$21.3M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$14.7M |
| 3 |
Salesforce
CRM
|
+$14M |
| 4 |
iShares MBS ETF
MBB
|
+$11.5M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$7.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$35M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$14.6M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$14.5M |
| 4 |
TJX Companies
TJX
|
+$8.92M |
| 5 |
Apple
AAPL
|
+$6.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.09% |
| 2 | Technology | 16.43% |
| 3 | Healthcare | 12.41% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 7.64% |
Similar funds
AC
DWM
RMDI
F
DCP
EW
AIM
PA
Curi RMB Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Curi RMB Capital held 504 positions worth $2.81B, up 4.7% from $2.68B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Curi RMB Capital withdrew a net $91.8M in Q4 2022, closing 41 positions and reducing 218 holdings. Its most notable exit was Edwards Lifesciences, an estimated $35M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Curi RMB Capital opened a new position in iShares MBS ETF worth $11.6M.
- Curi RMB Capital's largest Q4 2022 buy was iShares MBS ETF: 125,026 shares worth $11.6M.
- Curi RMB Capital added most to iShares MSCI Emerging Markets ETF in Q4 2022, an estimated $21.3M increase.
- Curi RMB Capital's biggest Q4 2022 reduction was TJX Companies, cutting an estimated $8.92M.
- Curi RMB Capital fully exited Edwards Lifesciences in Q4 2022, selling an estimated $35M.
- Curi RMB Capital's ten largest holdings make up 17% of its $2.81B portfolio in Q4 2022.
- Curi RMB Capital opened 39 new positions and closed 41 in Q4 2022.
- Curi RMB Capital's portfolio value rose 4.7% quarter-over-quarter to $2.81B.
Based on Curi RMB Capital's 13F filing for Q4 2022, filed 14 Feb 2023.